Top

Insights into Imaging

Published in:

Open Access 01-12-2015 | Pictorial Review

Pitfalls in Interpreting mp-MRI of the Prostate: A Pictorial Review with Pathologic Correlation

Authors: V. Panebianco, F. Barchetti, J. Barentsz, A. Ciardi, F. Cornud, J. Futterer, G. Villeirs

Published in: Insights into Imaging | Issue 6/2015

Abstract

Objectives

The purpose of this pictorial review is to present a wide spectrum of prostate multiparametric MRI (mp-MRI) pitfalls that may occur in clinical practice, with radiological and pathological correlation.

Methods

All examinations were performed according to ESUR Guidelines protocols.

Results and Conclusion

mp-MRI imaging of the prostate often leads to interpreting doubts and misdiagnosis due to the many interpretative pitfalls that a tissue, whether healthy or treated, may cause. These “false-positive” findings may occur in each stage of the disease history, from the primary diagnosis and staging, to the post-treatment stage, and whether they are caused by the tissue itself or are iatrogenic, their recognition is critical for proper treatment and management. Knowledge of these known pitfalls and their interpretation in the anatomical-radiological context can help radiologists avoid misdiagnosis and consequently mistreatment.

Main Messages

• Some physiological changes in the peripheral and central zone may simulate prostate cancer.

• Technical errors, such as mispositioned endorectal coils, can affect the mp-MRI interpretation.

• Physiological changes post-treatment can simulate recurrence

Walz J, Burnett AL, Costello AJ, Ja E, Graefen M, Guillonneau B et al (2010) Acritical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection incandidates for radical prostatectomy. Eur Urol 57:179–192CrossRefPubMed

Panebianco V, Barchetti F, Sciarra A, Ciardi A, Indino EL et al (2015) Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. Urol Oncol 33:17.e1–7CrossRef

Fütterer JJ (2007) MR imaging in local staging of prostate cancer. Eur J Radiol 63:328–334CrossRefPubMed

Hoeks CM, Barentsz JO, Hambrock T et al (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261:46–66CrossRefPubMed

Colleselli D, Hennenlotter J, Schilling D et al (2011) Impact of clinical parameters on the diagnostic accuracy of endorectal coil MRI for the detection of prostate cancer. Urol Int 86:393–398CrossRefPubMed

Hambrock T, Fütterer JJ, Huisman HJ et al (2008) Thirty two- channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility. Invest Radiol 43:686–694CrossRefPubMed

Franiel T, Lüdemann L, Rudolph B et al (2008) Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. Invest Radiol 43:481–487CrossRefPubMed

Tan CH, Wei W, Johnson V et al (2012) Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol 199:822–829PubMedCentralCrossRefPubMed

Wu LM, Xu JR, Gu HY et al (2012) Usefulness of diffusion weighted magnetic resonance imaging in the diagnosis of prostate cancer. Acad Radiol 19:1215–1224CrossRefPubMed

10.

Morgan VA, Riches SF, Giles S et al (2012) Diffusion weighted MRI for locally recurrent prostate cancer after external beam radiotherapy. AJR Am J Roentgenol 198:596–602CrossRefPubMed

11.

Heijmink SW, Scheenen TW, Fütterer JJ et al (2007) Prostate and lymph node proton magnetic resonance (MR) spectroscopic imaging with external array coils at 3 T to detect recurrent prostate cancer after radiation therapy. Invest Radiol 42:420–427CrossRefPubMed

12.

Caivano R, Cirillo P, Balestra A et al (2012) Prostate cancer in magnetic resonance imaging: diagnostic utilities of spectroscopic sequences. J Med Imaging Radiat Oncol 56:606–616CrossRefPubMed

13.

Vilanova JC, Barceló-Vidal C, Comet J et al (2011) Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer. AJR Am J Roentgenol 196:W715–W722CrossRefPubMed

14.

Rischke HC, Schäfer AO, Nestle U et al (2012) Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil. Radiat Oncol 7:185PubMedCentralCrossRefPubMed

15.

Chen YJ, Chu WC, Pu YS et al (2012) Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer. J Magn Reson Imaging 36:912–919CrossRefPubMed

16.

Verma S, Turkbey B, Muradyan N et al (2012) Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. AJR Am J Roentgenol 198:1277–1288CrossRefPubMed

17.

Panebianco V, Barchetti F, Sciarra A, Musio D, Forte V, Gentile V et al (2013) Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging. Eur Radiol 23(6):1745–1752CrossRefPubMed

18.

Vargas HA, Wassberg C, Akin O, Hricak H (2012) MR imaging of treated prostate cancer. Radiology 262(1):26–42CrossRefPubMed

19.

Liberman L, Menell JH (2002) Breast imaging reporting and data system (BI-RADS). Radiol Clin North Am 40(3):409–430CrossRefPubMed

20.

Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22(4):746–757PubMedCentralCrossRefPubMed

21.

Rosenkrantz AB, Taneja SS (2014) Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI. AJR Am J Roentgenol 202(1):109–120CrossRefPubMed

22.

Heijmink SW, Fütterer JJ, Hambrock T et al (2007) Prostate cancer: body-array versus endorectal coil MR imaging at 3 T-- comparison of image quality, localization, and staging performance. Radiology 244(1):184–195CrossRefPubMed

23.

Oto A, Kayhan A, Jiang Y et al (2010) Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 257(3):715–723CrossRefPubMed

24.

McNeal JE, Redwine EA, Freiha FS, Stamey TA (1988) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12(12):897–906CrossRefPubMed

25.

Greene DR, Wheeler TM, Egawa S et al (1991) A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol 146(4):1069–1076PubMed

26.

Shannon BA, McNeal JE, Cohen RJ (2003) Transition zone carcinoma of the prostate gland: a common indolent tumour type that occasionally manifests aggressive behaviour. Pathology 35(6):467–471CrossRefPubMed

27.

Akin O, Sala E, Moskowitz CS et al (2006) Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 239(3):784–792CrossRefPubMed

28.

Kim CK, Park BK, Han JJ et al (2007) Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results. J Comput Assist Tomogr 31(3):449–454CrossRefPubMed

29.

Tamada T, Sone T, Jo Y et al (2008) Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging 28(3):720–726CrossRefPubMed

30.

Kim CK, Park BK, Lee HM, Kwon GY (2007) Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Invest Radiol 42(12):842–847CrossRefPubMed

31.

Sato C, Naganawa S, Nakamura T et al (2005) Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 21(3):258–262CrossRefPubMed

32.

Hoeks CM, Hambrock T, Yakar D, de Kaa CA H, Feuth T, Witjes JA et al (2013) Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. Radiology 266(1):207–217CrossRefPubMed

33.

Bour L, Schull A, Delongchamps NB, Beuvon F, Muradyan N, Legmann P et al (2013) Multiparametric MRI features of granulomatous prostatitis and tubercular prostate abscess. Diagn Interv Imaging 94(1):84–90CrossRefPubMed

34.

Bouyé S, Potiron E, Puech P, Leroy X, Lemaitre L, Villers A (2009) Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology. Prostate 69(1):105–113CrossRefPubMed

35.

Jager GJ, Barentsz JO, Oosterhof GO, Witjes JA, Ruijs SJ (1996) Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional T1- weighted magnetization-prepared-rapid gradient- echo sequence. AJR Am J Roentgenol 167:1503–1507CrossRefPubMed

36.

Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH et al (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348(25):2491–2499CrossRefPubMed

37.

Young HH (1905) VIII. Conservative perineal prostatectomy: the results of two years’ experience and report of seventy-five cases. Ann Surg 41(4):549–557PubMedCentralPubMed

38.

Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR (2004) The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 22(11):2141–2149PubMedCentralCrossRefPubMed

39.

Bianco FJ Jr, Scardino PT, Eastham JA (2005) Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (“trifecta”). Urology 66(5 Suppl):83–94CrossRefPubMed

40.

Eastham JA, Scardino PT, Kattan MW (2008) Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram. J Urol 179(6):2207–2210, discussion 2210–2211 PubMedCentralCrossRefPubMed

41.

Patel VR, Coelho RF, Chauhan S et al (2010) Continence, potency and oncological outcomes after robotic-assisted radical prostatectomy: early trifecta results of a high-volume surgeon. BJU Int 106(5):696–702CrossRefPubMed

42.

Cirillo S, Petracchini M, Scotti L et al (2009) Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 19(3):761–769CrossRefPubMed

43.

Sella T, Schwartz LH, Swindle PW et al (2004) Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231(2):379–385CrossRefPubMed

44.

Sella T, Schwartz LH, Hricak H (2006) Retained seminal vesicles after radical prostatectomy: frequency, MRI characteristics, and clinical relevance. AJR Am J Roentgenol 186(2):539–546CrossRefPubMed

45.

Hricak H, Carrington BM (1991) MRI of the pelvis: a text atlas. Martin Dunitz, London

46.

Sciarra A, Panebianco V, Salciccia S et al (2008) Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 54(3):589–600CrossRefPubMed

47.

Sfoungaristos S, Kontogiannis S, Perimenis P (2013) Early continence recovery after preservation of maximal urethral length until the level of verumontanum during radical prostatectomy: primary oncological and functional outcomes after 1 year of follow-up. Biomed Res Int 2013:426208PubMedCentralCrossRefPubMed

48.

Muezzinoglu B, Erdamar S, Chakraborty S, Wheeler TM (2001) Verumontanum mucosal gland hyperplasia is associated with atypical adenomatous hyperplasia of the prostate. Arch Pathol Lab Med 125(3):358–360PubMed

49.

Cellini N, Morganti AG, Mattiucci GC et al (2002) Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning. Int J Radiat Oncol Biol Phys 53(3):595–599CrossRefPubMed

50.

Pucar D, Hricak H, Shukla-Dave A et al (2007) Clinically signifi cant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys 69(1):62–69CrossRefPubMed

51.

Pucar D, Shukla-Dave A, Hricak H et al (2005) Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology 236(2):545–553PubMedCentralCrossRefPubMed

52.

Rouvière O, Valette O, Grivolat S et al (2004) Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor—correlation with biopsy findings. Urology 63(5):922–927CrossRefPubMed

53.

Kim CK, Park BK, Lee HM (2009) Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J Magn Reson Imaging 29(2):391–397CrossRefPubMed

54.

Akin O, Gultekin DH, Vargas HA et al (2011) Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results. Eur Radiol 21(9):1970–1978PubMedCentralCrossRefPubMed

55.

Mueller-Lisse UG, Swanson MG, Vigneron DB et al (2001) Time-Dependent Effects of Hormone-Deprivation Therapy on Prostate Metabolism as Detected by Combined Magnetic Resonance Imaging and 3D Magnetic Resonance Spectroscopic Imaging. Magn Reson Med 46:49–57CrossRefPubMed

56.

Muller BG, Fütterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J et al (2014) The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel. BJU Int 113(2):218–227PubMedCentralCrossRefPubMed

57.

Kalbhen CL, Hricak H, Shinohara K et al (1996) Prostate carcinoma: MR imaging findings after cryosurgery. Radiology 198:807–811CrossRefPubMed

58.

Kirkham AP, Emberton M, Hoh IM, Illing RO, Freeman AA, Allen C (2008) MR imaging of prostate after treatment with high-intensity focused ultrasound. Radiology 246:833–844CrossRefPubMed

59.

Haider MA, Davidson SR, Kale AV et al (2007) Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide. Radiology 244:196–204CrossRefPubMed

60.

Parivar F, Hricak H, Shinohara K (1996) Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and threedimensional proton magnetic resonance spectroscopy. Urology 48:594–599CrossRefPubMed

61.

Rouvière O, Lyonnet D, Raudrant A et al (2001) MRI appearance of prostate following transrectal HIFU ablation of localized cancer. Eur Urol 40:265–274CrossRefPubMed

62.

Kim CK, Park BK, Lee HM, Kim SS, Kim E (2008) MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. AJR Am J Roentgenol 190(5):1180–1186CrossRefPubMed

63.

Rosenkrantz AB, Scionti SM, Mendrinos S, Taneja SS (2011) Role of MRI in minimally invasive focal ablative therapy for prostate cancer. AJR Am J Roentgenol 197(1):W90–W96CrossRefPubMed

64.

Kim CK, Park BK, Lee HM, Kim SS, Kim E (2008) MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. AJR 190:1180–1186CrossRefPubMed

65.

Yang DM, Jung DH, Kim H et al (2004) Retroperitoneal cystic masses: CT, clinical, and pathologic findings and literature review. RadioGraphics 24(5):1353–1365CrossRefPubMed

Title: Pitfalls in Interpreting mp-MRI of the Prostate: A Pictorial Review with Pathologic Correlation
Authors: V. Panebianco
F. Barchetti
J. Barentsz
A. Ciardi
F. Cornud
J. Futterer
G. Villeirs
Publication date: 01-12-2015
Publisher: Springer Berlin Heidelberg
Published in: Insights into Imaging / Issue 6/2015
Electronic ISSN: 1869-4101
DOI: https://doi.org/10.1007/s13244-015-0426-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pitfalls in Interpreting mp-MRI of the Prostate: A Pictorial Review with Pathologic Correlation

Abstract

Objectives

Methods

Results and Conclusion

Main Messages

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Methods

Results and Conclusion

Main Messages

Please log in to get access to this content

Other articles of this Issue 6/2015

Hepatic tuberculosis: a multimodality imaging review

The consequences of the economic crisis in radiology

Cardiovascular imaging in children and adults following Kawasaki disease

Inferior vena cava anomalies and variations: imaging and rare clinical findings

Extracutaneous melanomas: a primer for the radiologist

Giant colonic diverticulum: radiographic and MDCT characteristics